

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 157.83 | 137.20 | 115.58 | 100.05 | 71.15 |
| Total Expenses | 146.26 | 121.99 | 102.62 | 91.42 | 67.38 |
| Profit Before Tax | 11.57 | 15.21 | 12.95 | 8.63 | 3.77 |
| Profit After Tax | 7.84 | 11.50 | 9.82 | 6.69 | 2.73 |
| Operating Profit After Depreciation | 15.24 | 17.37 | 16.06 | 10.33 | 4.92 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 24.16 | 19.64 | 18.81 | 4.20 | 4.72 |
| Total Non Current Assets | 58.47 | 20.44 | 19.30 | 15.32 | 8.71 |
| Total Current Assets | 139.92 | 65.01 | 51.31 | 43.68 | 25.47 |
| Total Assets | 198.39 | 85.45 | 70.61 | 59 | 34.18 |
| Total Shareholder's Fund | 109.46 | 58.78 | 22.56 | 13.10 | 7.02 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -29.12 | 4.92 | 8.59 | 11.80 | 7.29 |
| Net Cash Used In Investing Activities | -27.24 | -3.79 | -4.96 | -6.63 | -5 |
| Net Cash Used In Financing Activities | 79.29 | 4.81 | -3.10 | -1.70 | -1.16 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 139.05 | 123.98 | 102.65 | 74.96 | 55.18 |
| Total Expenses | 127.44 | 109.12 | 90.38 | 67.56 | 51.42 |
| Profit Before Tax | 11.61 | 14.86 | 12.26 | 7.41 | 3.76 |
| Profit After Tax | 8.47 | 11.09 | 9.15 | 5.50 | 2.72 |
| Operating Profit After Depreciation | 14.30 | 16.60 | 15.26 | 9.06 | 4.88 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 17.07 | 16.47 | 15.58 | 3.74 | 4.25 |
| Total Non Current Assets | 37.84 | 17.51 | 16.41 | 15.12 | 8.50 |
| Total Current Assets | 128.29 | 60.23 | 44 | 33.93 | 22.31 |
| Total Assets | 166.13 | 77.74 | 60.42 | 49.06 | 30.81 |
| Total Shareholder's Fund | 105.71 | 57.75 | 21.70 | 12.55 | 7.05 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -25.95 | 3.13 | 7.35 | 9.14 | 6.82 |
| Net Cash Used In Investing Activities | -23.15 | -3.30 | -2.58 | -7.17 | -4.59 |
| Net Cash Used In Financing Activities | 74.21 | 5.03 | -3 | -1.66 | -1.12 |
No data available
No data available
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 13 November 2025
07 Nov 2025, 09:58 am
On 25 September 2025
22 Aug 2025, 04:52 pm
On 21 August 2025
14 Aug 2025, 11:19 am
On 23 May 2025
12 May 2025, 10:25 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.